GLSI (STOCKS)
Greenwich LifeSciences, Inc.
$27.279700
-0.710300 (-2.54%)
Prev close: $27.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Snehal S. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $383.95M
- Employees
- 8
- P/E (TTM)
- -18.94
- P/B (TTM)
- 175.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.30 | $-0.30 | +0.0009 | +0.30% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.24 | -0.0552 | -22.55% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.24 | -0.0052 | -2.12% |
|
Dec 2024 (Q4)
|
$-0.61 | $-0.21 | -0.3958 | -184.78% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $19.59M |
| Research and Development | $15.79M |
| Other Operating Expenses | $3.80M |
| Operating Income/Loss | -$19.59M |
| Income/Loss From Continuing Operations After Tax | -$19.48M |
| Income/Loss From Continuing Operations Before Tax | -$19.48M |
| Net Income/Loss | -$19.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.46 |
| Diluted Earnings Per Share | -$1.46 |
| Basic Average Shares | 13,440,899 |
| Diluted Average Shares | 40,228,459 |
| Assets | $3.81M |
| Current Assets | $3.81M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.62M |
| Current Liabilities | $1.62M |
| Wages | $206.83K |
| Other Current Liabilities | $1.42M |
| Noncurrent Liabilities | $0.00 |
| Equity | $2.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.18M |
| Liabilities And Equity | $3.81M |
| Net Cash Flow From Operating Activities | -$8.59M |
| Net Cash Flow From Operating Activities, Continuing | -$8.59M |
| Net Cash Flow | -$7.27M |
| Net Cash Flow, Continuing | -$7.27M |
| Comprehensive Income/Loss | -$19.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.48M |
| Other Comprehensive Income/Loss | $0.00 |